DTC Act of 2025

Issues related to prescription drug prices. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S.229 DTC Act of 2025.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Draft, the Expedited Access to Biosimilars Act (no bill number) - Rep. Langworthy, Nick - Biosimilar approval requirements H.R. 1 - One Big Beautiful Bill Act - Rep. Arrington, Jodey - Medicaid eligibility and state financing, Marketplace coverage and enrollment, Health Savings Account expansion, Pharmacy Benefit Manager financing and regulation H.R. 843 - Prompt Approval of Safe Generic Drugs Act - Rep. Barragan, Nanette Diaz - Generic drugs applications and approvals H.R. 946 - ORPHAN Cures Act - Rep. Joyce, John - Medicare Drug Negotiation Program H.R. 950 - Saving Seniors Money on Prescriptions Act - Rep. Landsman, Greg - PBM reporting requirements for MA/Part D plans. H.R. 1117 - Responsibility in Drug Advertising Act - Rep. DeLauro, Rosa - Direct-to-consumer ads H.R. 1244 - Reducing Drug Prices for Seniors Act - Rep. Davis, Donald - Coinsurance for Part D drugs H.R. 2214 - DRUG Act - Rep. Miller-Meeks, Mariannette - PBM contracts H.R. 2450 - Prescription Drug Transparency and Affordability Act - Rep. McDonald Rivet, Kristen - PBM transparency H.R. 3493 - Global Fairness in Drug Pricing Act - Rep. Khanna, Ro - Prescription drug international reference pricing H.R. 3546 - Prescription Drug Price Relief Act - Rep. Khanna, Ro - Prescription drug patent reform H.R. 3775 - Fair Prescription Drug Prices for Americans Act - Rep. Van Drew, Jefferson - Prescription drug and biological product international reference pricing H.R. 3789 - DTC Act - Rep. Taylor, David - Direct-to-consumer prescription advertising transparency H.R. 4139 - Cutting Copays Act - Rep. McGarvey, Morgan - Medicare cost-sharing for generic drugs H.R. 4231 - Treat and Reduce Obesity Act - Rep. Kelly, Mike - Medicare coverage of obesity drugs H.R. 4317 - PBM Reform Act - Rep. Carter, Earl L. Buddy - PBM contracting requirements and transparency H.R. 4605 - End Prescription Drug Ads Now Act - Rep. Nadler, Jerrold - Ban on DTC drug ads H.R. 4623 - Plain Prescription Prices Act - Rep. Williams, Nikema - Transparency requirements for DTC drug ads H.R. 5094 - Protect Patients from Costly Care Act - Rep. Pappas, Chris - Repeal of Medicaid cost sharing requirements for drugs; Orphan drug inclusion in Medicare Drug Price Negotiation Program H.R. 5197 - Protect Beneficiaries from Middlemen Act - Rep. Malliotakis, Nicole - Medicare cost-sharing limit for drugs H.R. 5526 - Biosimilar Red Tape Elimination Act - Rep. Pfluger, Austin - Biosimilars approval procedures H.R. 6255 - Affordable Insulin Now Act - Rep. Craig, Angie - require cost-sharing for certain insulin products H.R. 7837 - Most Favored Patient Act - Rep. Meuser, Daniel - MFN demonstration H.R. 8779 - PBM Act - Rep. Harshbarger, Diana - PBM ownership requirements S. 229 - DTC Act - Sen. Durbin, Richard - Drug advertising requirements S. 483 - Responsibility in Drug Advertising Act - Sen. King, Angus - Drug advertising requirements S. 526 - Pharmacy Benefit Manager Transparency Act of 2025 - Sen. Grassley, Chuck - PBM reporting requirements S. 529 - Capping Prescription Costs Act - Sen. Warnock, Raphael - Drug copay caps S. 652 - Protecting Patients from Deceptive Drugs Ads Act - Sen. Durbin, Richard - Drug advertising requirements S. 882 - Patients Before Middlemen Act - Sen. Blackburn, Marsha - PBM reforms S. 891 - Bipartisan Health Care Act - Sen. Wyden, Ron - PBM reforms and transparency S. 1040 - Drug Competition Enhanced Act - Sen. Cornyn, John - Drug patent reform S. 1041 - Affordable Prescriptions for Patients Act - Sen. Cornyn, John - Patent issues S. 1095 - Stop STALLING Act - Sen. Klobuchar, Amy - Drug patent reform S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act - Sen. Klobuchar, Amy - Drug patent reform S. 1414 - Expedited Access to Biosimilars Act - Sen. Paul, Rand - Biosimilars assessment and approval S. 1587 - Fair Prescription Drug Prices for Americans Act - Sen. Hawley, Josh - Prescription drug international reference pricing S. 1753 - End Price Gouging for Medications Act - Sen. Merkley, Jeff - Prescription drug international reference pricing S. 1818 - Prescription Drug Price Relief Act - Sen. Sanders, Bernard - Prescription drug patent reform S. 1954 - Biosimilar Red Tape Elimination Act - Sen. Lee, Mike - Biological product assessment and approval S. 1973 - Treat and Reduce Obesity Act - Sen. Cassidy, Bill - Medicare coverage for obesity drugs S. 2345 - Short on Competition Act - Sen. Klobuchar, Amy - Expedited approval for generic drugs S. 2447 - Repealing the Trump Sick Tax Act - Sen. Welch, Peter - Repeal of Medicaid cost sharing requirements for drugs; Orphan drug inclusion in Medicare Drug Price Negotiation Program S. 2620 - REMEDY Act - Sen. Durbin, Richard - Expedited approvals for certain drug approvals S. 2658 - Medication Affordability and Patient Integrity Act - Sen. Hassan, Margaret - FDA and USPTO coordination S. 3014 - Ensuring Timely Access to Generics Act - Sen. Shaheen, Jeanne - Generic drug approval S. 4332 - Medication Competition Act - Sen. Hassan, Maggie - Pharmaceutical exclusivity periods S. 4355 - Drug Deal Disclosure Act - Sen. Wyden, Ron - Federal MFN agreement transparency S. 4509 - PBM Act - Sen. Warren, Elizabeth - PBM ownership requirements Issues related to the implementation of Inflation Reduction Act - Medicare negotiation; cost-sharing and coverage of weight loss drugs/GLP-1s; high priced drugs; patent reforms; generic approval; Pharmacy Benefit Managers; PBM-related issues; step therapy; copay caps; insulin costs; and copay coupons.

Prescription drug pricing issues. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S. 229 - The Drug-price Transparency for Consumers (DTC) Act of 2025..

Client expense: Not reported · Firm income: $90,000

No Bill No. - Reducing Medically Unnecessary Delays in Care Act No Bill No. - Global Health Empowerment and Rights (Global HER) Act No Bill No. - WHO withdrawal No Bill No. - Chronic Disease Flexible Coverage Act No Bill No. - Rural Physician Workforce Production Act No Bill No. - Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics (BLOCKING) Act No Bill No. - Protecting Patients from Deceptive Drug Ads Online Act No Bill No. - Protect Health Savings Account Act No Bill No. - HHS reorganization No Bill No. - Workforce Mobility Act No Bill No. - Health Care Workforce Expansion Act No Bill No. - TRUTH in Labeling Act No Bill No. - NIH Clinical Trial Integrity Act No Bill No. - Modernizing Opioid Treatment Access Act 2.0 NO Bill NO. - Follow the Science Act (H.R. 8765) - Prioritizing Primary Care Act (H.R. 21/S.6) - Born-Alive Abortion Survivors Protection Act (H.R. 1061) - Protecting Sensitive Locations Act (S. 229) - Drug Price Transparency for Consumers (DTC) Act (H.R. 777) - Closing the College Hunger Gap Act (H.R. 957) - Parity Enforcement Act (H.R. 846/S.589) - Stop Anti-Abortion Disinformation (SAD) Act (H.R. 929/S.266) - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act (H.R. 1670/S. 797) - Family Building FEHB Fairness Act (S. 1538) - Rural Seniors Act (H.R. 999/S. 422) - Right to Contraception Act (H.R. 2818/S. 1447) - Early Childhood Nutrition Improvement Act (H.R. 2559/S. 1420) - Child Care Nutrition Enhancement Act (H.R. 2495/S. 1971) - Nutrition Counseling Aiding Recovery for Eating Disorders (CARE) Act (H.R. 2483) - SUPPORT for Patients and Communities Reauthorization Act (H.R. 2762/S. 1394) - Expanding Access to Family Planning Act (H.R. 2717/S. 1320) - Servicewoman and Veterans Menopause Research Act (H.R. 1) - One Big Beautiful Bill Act (H.R. 1026/s. 1719) - Improving Seniors' Timely Access to Care Act (H.R. 3757) - Supporting Healthy Mothers and Infants Act (S. 5469) - SHINE for Autumn Act (S. 1562/H.R. 1197) - PREEMIE Reauthorization Act (H.R. 3670) - IHS Provider Expansion Act (S. 2072) - MORE Savings Act (S. 2169) - Rural Hospital Cybersecurity Act (S. 1847/H.R. 3672) - Supporting Healthy Moms and Babies Act (H.R. 3885) - TEAMS Act (H.R. 3942) - Keeping Obstetrics Local Act (H.R. 4837) - Written Informed Consent Act (H.R. 3013) - Vaccine Transportation Act (H.R. 6468) - Rural Residency Planning and Development Act of 2025 (H.R. 6760) - Protecting Access to Affordable Coverage Act (H.R. 5461/S.2211) - Special Diabetes Program Reauthorization Act (H.R. 5684) - Medical Foods and Formulas Access Act (H.R. 7064) - AI in Healthcare Efficiency and Study Act (S. 4027/H.R. 6248) - Healthy Competition for Better Care Act (S. 3842) - 21st Century WIC Act (H.R. 5488) - Special Diabetes Program for Indians Reauthorization Act (S. 3274/H.R. 6242) - Healthy Maternity and Obstetric Medicine (MOM) Act (H.R. 5360) - AI Warnings and Resources for Education (AWARE) Act (H.R. 6353) - Algorithmic Choice and Transparency Act (H.R. 6292) - Don't Sell Kid's Data Act (S. 3618/H.R. 6259) - No Fentanyl on Social Media Act (H.R. 6498) - Safeguarding Adolescents from Exploitative (SAFE) Bots Act (H.R. 6290) - Safe Social Media Act (H.R. 7227/S.3698) - Mental Health and Making Access More Affordable (MAMA) Act (H.R. 7444) - Protecting Rural Telehealth Access Act (H.R. 9257) - Primary and Behavioral Health Care Access Act (S. 4927) - Rural Hospital Emergency Room Guarantee Act (H.R. 7267/ S. 3706) - Produce Prescription for Veterans Act (H.R. 3747) - Accelerating Access to Dementia and Alzheimer's Provider Training Act (H.R. 8390) - National Food as Medicine Program Act of 2026 (H.R. 8245) - Strengthening the Vaccine for Children Program Act of 2026 (H.R. 7973) - Momnibus Act

S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now

Client expense: Not reported · Firm income: Not reported

Government targets: SENATE

S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now

Client expense: Not reported · Firm income: Not reported

Issues related to prescription drug prices. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S.229 DTC Act of 2025.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Draft, Expedited Access to Biosimilars Act (no bill number) - Rep. Langworthy, Nick - Biosimilar approval requirements H.R. 1 - One Big Beautiful Bill Act - Rep. Arrington, Jodey - Medicaid eligibility and state financing, Marketplace coverage and enrollment, Health Savings Account expansion, Pharmacy Benefit Manager financing and regulation H.R. 843 - Prompt Approval of Safe Generic Drugs Act - Rep. Barragan, Nanette Diaz - Generic drugs applications and approvals H.R. 946 - ORPHAN Cures Act - Rep. Joyce, John - Medicare Drug Negotiation Program H.R. 950 - Saving Seniors Money on Prescriptions Act - Rep. Landsman, Greg - PBM reporting requirements for MA/Part D plans. H.R. 1117 - Responsibility in Drug Advertising Act - Rep. DeLauro, Rosa - Direct-to-consumer ads H.R. 1244 - Reducing Drug Prices for Seniors Act - Rep. Davis, Donald - Coinsurance for Part D drugs H.R. 2214 - DRUG Act - Rep. Miller-Meeks, Mariannette - PBM contracts H.R. 2450 - Prescription Drug Transparency and Affordability Act - Rep. McDonald Rivet, Kristen - PBM transparency H.R. 3493 - Global Fairness in Drug Pricing Act - Rep. Khanna, Ro - Prescription drug international reference pricing H.R. 3546 - Prescription Drug Price Relief Act - Rep. Khanna, Ro - Prescription drug patent reform H.R. 3775 - Fair Prescription Drug Prices for Americans Act - Rep. Van Drew, Jefferson - Prescription drug and biological product international reference pricing H.R. 3789 - DTC Act - Rep. Taylor, David - Direct-to-consumer prescription advertising transparency H.R. 4139 - Cutting Copays Act - Rep. McGarvey, Morgan - Medicare cost-sharing for generic drugs H.R. 4231 - Treat and Reduce Obesity Act - Rep. Kelly, Mike - Medicare coverage of obesity drugs H.R. 4317 - PBM Reform Act - Rep. Carter, Earl L. Buddy - PBM contracting requirements and transparency H.R. 4605 - End Prescription Drug Ads Now Act - Rep. Nadler, Jerrold - Ban on DTC drug ads H.R. 4623 - Plain Prescription Prices Act - Rep. Williams, Nikema - Transparency requirements for DTC drug ads H.R. 5094 - Protect Patients from Costly Care Act - Rep. Pappas, Chris - Repeal of Medicaid cost sharing requirements for drugs; Orphan drug inclusion in Medicare Drug Price Negotiation Program H.R. 5197 - Protect Beneficiaries from Middlemen Act - Rep. Malliotakis, Nicole - Medicare cost-sharing limit for drugs H.R. 6255 - Affordable Insulin Now Act - Rep. Craig, Angie - require cost-sharing for certain insulin products H.R. 7837 - Most Favored Patient Act - Rep. Meuser, Daniel - MFN demonstration S. 229 - DTC Act - Sen. Durbin, Richard - Drug advertising requirements S. 483 - Responsibility in Drug Advertising Act - Sen. King, Angus - Drug advertising requirements S. 526 - Pharmacy Benefit Manager Transparency Act of 2025 - Sen. Grassley, Chuck - PBM reporting requirements S. 529 - Capping Prescription Costs Act - Sen. Warnock, Raphael - Drug copay caps S. 652 - Protecting Patients from Deceptive Drugs Ads Act - Sen. Durbin, Richard - Drug advertising requirements S. 882 - Patients Before Middlemen Act - Sen. Blackburn, Marsha - PBM reforms S. 891 - Bipartisan Health Care Act - Sen. Wyden, Ron - PBM reforms and transparency S. 1040 - Drug Competition Enhanced Act - Sen. Cornyn, John - Drug patent reform S. 1041 - Affordable Prescriptions for Patients Act - Sen. Cornyn, John - Patent issues S. 1095 - Stop STALLING Act - Sen. Klobuchar, Amy - Drug patent reform S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act - Sen. Klobuchar, Amy - Drug patent reform S. 1414 - Expedited Access to Biosimilars Act - Sen. Paul, Rand - Biosimilars assessment and approval S. 1587 - Fair Prescription Drug Prices for Americans Act - Sen. Hawley, Josh - Prescription drug international reference pricing S. 1753 - End Price Gouging for Medications Act - Sen. Merkley, Jeff - Prescription drug international reference pricing S. 1818 - Prescription Drug Price Relief Act - Sen. Sanders, Bernard - Prescription drug patent reform S. 1954 - Biosimilar Red Tape Elimination Act - Sen. Lee, Mike - Biological product assessment and approval S. 1973 - Treat and Reduce Obesity Act - Sen. Cassidy, Bill - Medicare coverage for obesity drugs S. 2345 - Short on Competition Act - Sen. Klobuchar, Amy - Expedited approval for generic drugs S. 2447 - Repealing the Trump Sick Tax Act - Sen. Welch, Peter - Repeal of Medicaid cost sharing requirements for drugs; Orphan drug inclusion in Medicare Drug Price Negotiation Program S. 2620 - REMEDY Act - Sen. Durbin, Richard - Expedited approvals for certain drug approvals Issues related to the implementation of Inflation Reduction Act - Medicare negotiation; cost-sharing and coverage of weight loss drugs/GLP-1s; high priced drugs; patent reforms; Pharmacy Benefit Managers; PBM related issues; and copay coupons.

Prescription drug pricing issues. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S. 229 - The Drug-price Transparency for Consumers (DTC) Act of 2025..

Client expense: Not reported · Firm income: $90,000

No Bill No. - Reducing Medically Unnecessary Delays in Care Act No Bill No. - Global Health Empowerment and Rights (Global HER) Act No Bill No. - WHO withdrawal No Bill No. - Chronic Disease Flexible Coverage Act No Bill No. - Rural Physician Workforce Production Act No Bill No. - Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics (BLOCKING) Act No Bill No. - Protecting Patients from Deceptive Drug Ads Online Act No Bill No. - Protect Health Savings Account Act No Bill No. - HHS reorganization No Bill No. - Workforce Mobility Act No Bill No. - Health Care Workforce Expansion Act No Bill No. - TRUTH in Labeling Act No Bill No. - NIH Clinical Trial Integrity Act (H.R. 21/S.6) - Born-Alive Abortion Survivors Protection Act (H.R. 1061) - Protecting Sensitive Locations Act (S. 229) - Drug Price Transparency for Consumers (DTC) Act (H.R. 777) - Closing the College Hunger Gap Act (H.R. 957) - Parity Enforcement Act (H.R. 846/S.589) - Stop Anti-Abortion Disinformation (SAD) Act (H.R. 929/S.266) - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act (H.R. 1670/S. 797) - Family Building FEHB Fairness Act (S. 1538) - Rural Seniors Act (H.R. 999/S. 422) - Right to Contraception Act (H.R. 2818/S. 1447) - Early Childhood Nutrition Improvement Act (H.R. 2559/S. 1420) - Child Care Nutrition Enhancement Act (H.R. 2495/S. 1971) - Nutrition Counseling Aiding Recovery for Eating Disorders (CARE) Act (H.R. 2483) - SUPPORT for Patients and Communities Reauthorization Act (H.R. 2762/S. 1394) - Expanding Access to Family Planning Act (H.R. 2717/S. 1320) - Servicewoman and Veterans Menopause Research Act (H.R. 1) - One Big Beautiful Bill Act (H.R. 1026/s. 1719) - Improving Seniors' Timely Access to Care Act (H.R. 3757) - Supporting Healthy Mothers and Infants Act (S. 5469) - SHINE for Autumn Act (S. 1562/H.R. 1197) - PREEMIE Reauthorization Act (H.R. 3670) - IHS Provider Expansion Act (S. 2072) - MORE Savings Act (S. 2169) - Rural Hospital Cybersecurity Act (S. 1847/H.R. 3672) - Supporting Healthy Moms and Babies Act (H.R. 3885) - TEAMS Act (H.R. 3942) - Keeping Obstetrics Local Act (H.R. 4837) - Written Informed Consent Act (H.R. 3013) - Vaccine Transportation Act (H.R. 6468) - Rural Residency Planning and Development Act of 2025 (H.R. 6760) - Protecting Access to Affordable Coverage Act (H.R. 5461/S.2211) - Special Diabetes Program Reauthorization Act (H.R. 5684) - Medical Foods and Formulas Access Act (H.R. 7064) - AI in Healthcare Efficiency and Study Act (S. 4027/H.R. 6248) - Healthy Competition for Better Care Act (S. 3842) - 21st Century WIC Act (H.R. 5488) - Special Diabetes Program for Indians Reauthorization Act (S. 3274/H.R. 6242) - Healthy Maternity and Obstetric Medicine (MOM) Act (H.R. 5360) - AI Warnings and Resources for Education (AWARE) Act (H.R. 6353) - Algorithmic Choice and Transparency Act (H.R. 6292) - Don't Sell Kid's Data Act (S. 3618/H.R. 6259) - No Fentanyl on Social Media Act (H.R. 6498) - Safeguarding Adolescents from Exploitative (SAFE) Bots Act (H.R. 6290) - Safe Social Media Act (H.R. 7227/S.3698) - Mental Health and Making Access More Affordable (MAMA) Act (H.R. 7444) - Protecting Rural Telehealth Access Act

Issues related to prescription drug prices. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S.229 DTC Act of 2025.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1 - One Big Beautiful Bill Act - Rep. Arrington, Jodey - Medicaid eligibility and state financing, Marketplace coverage and enrollment, Health Savings Account expansion, Pharmacy Benefit Manager financing and regulation H.R. 843 - Prompt Approval of Safe Generic Drugs Act - Rep. Barragan, Nanette Diaz - Generic drugs applications and approvals H.R. 946 - ORPHAN Cures Act - Rep. Joyce, John - Medicare Drug Negotiation Program H.R. 950 - Saving Seniors Money on Prescriptions Act - Rep. Landsman, Greg - PBM reporting requirements for MA/Part D plans. H.R. 1117 - Responsibility in Drug Advertising Act - Rep. DeLauro, Rosa - Direct-to-consumer ads H.R. 1244 - Reducing Drug Prices for Seniors Act - Rep. Davis, Donald - Coinsurance for Part D drugs H.R. 2214 - DRUG Act - Rep. Miller-Meeks, Mariannette - PBM contracts H.R. 2450 - Prescription Drug Transparency and Affordability Act - Rep. McDonald Rivet, Kristen - PBM transparency H.R. 3493 - Global Fairness in Drug Pricing Act - Rep. Khanna, Ro - Prescription drug international reference pricing H.R. 3546 - Prescription Drug Price Relief Act - Rep. Khanna, Ro - Prescription drug patent reform H.R. 3775 - Fair Prescription Drug Prices for Americans Act - Rep. Van Drew, Jefferson - Prescription drug and biological product international reference pricing H.R. 3789 - DTC Act - Rep. Taylor, David - Direct-to-consumer prescription advertising transparency H.R. 4139 - Cutting Copays Act - Rep. McGarvey, Morgan - Medicare cost-sharing for generic drugs H.R. 4231 - Treat and Reduce Obesity Act - Rep. Kelly, Mike - Medicare coverage of obesity drugs H.R. 4317 - PBM Reform Act - Rep. Carter, Earl L. Buddy - PBM contracting requirements and transparency H.R. 4605 - End Prescription Drug Ads Now Act - Rep. Nadler, Jerrold - Ban on DTC drug ads H.R. 4623 - Plain Prescription Prices Act - Rep. Williams, Nikema - Transparency requirements for DTC drug ads H.R. 5094 - Protect Patients from Costly Care Act - Rep. Pappas, Chris - Repeal of Medicaid cost sharing requirements for drugs; Orphan drug inclusion in Medicare Drug Price Negotiation Program H.R. 5197 - Protect Beneficiaries from Middlemen Act - Rep. Malliotakis, Nicole - Medicare cost-sharing limit for drugs H.R. 6255 - Affordable Insulin Now Act - Rep. Craig, Angie - require cost-sharing for certain insulin products S. 229 - DTC Act - Sen. Durbin, Richard - Drug advertising requirements S. 483 - Responsibility in Drug Advertising Act - Sen. King, Angus - Drug advertising requirements S. 526 - Pharmacy Benefit Manage Transparency - Sen. Grassley, Chuck - PBM reporting requirements S. 529 - Capping Prescription Costs Act - Sen. Warnock, Raphael - Drug copay caps S. 652 - Protecting Patients from Deceptive Drugs Ads Act - Sen. Durbin, Richard - Drug advertising requirements S. 882 - Patients Before Middlemen Act - Sen. Blackburn, Marsha - PBM reforms S. 891 - Bipartisan Health Care Act - Sen. Wyden, Ron - PBM reforms and transparency S. 1040 - Drug Competition Enhanced Act - Sen. Cornyn, John - Drug patent reform S. 1041 - Affordable Prescriptions for Patients Act - Sen. Cornyn, John - Patent issues S. 1095 - Stop STALLING Act - Sen. Klobuchar, Amy - Drug patent reform S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act - Sen. Klobuchar, Amy - Drug patent reform S. 1414 - Expedited Access to Biosimilars Act - Sen. Paul, Rand - Biosimilars assessment and approval S. 1587 - Fair Prescription Drug Prices for Americans Act - Sen. Hawley, Josh - Prescription drug international reference pricing S. 1753 - End Price Gouging for Medications Act - Sen. Merkley, Jeff - Prescription drug international reference pricing S. 1818 - Prescription Drug Price Relief Act - Sen. Sanders, Bernard - Prescription drug patent reform S. 1954 - Biosimilar Red Tape Elimination Act - Sen. Lee, Mike - Biological product assessment and approval S. 1973 - Treat and Reduce Obesity Act - Sen. Cassidy, Bill - Medicare coverage for obesity drugs S. 2345 - Short on Competition Act - Sen. Klobuchar, Amy - Expedited approval for generic drugs S. 2447 - Repealing the Trump Sick Tax Act - Sen. Welch, Peter - Repeal of Medicaid cost sharing requirements for drugs; Orphan drug inclusion in Medicare Drug Price Negotiation Program S. 2620 - REMEDY Act - Sen. Durbin, Richard - Expedited approvals for certain drug approvals Issues related to the implementation of Inflation Reduction Act - Medicare negotiation; cost-sharing and coverage of weight loss drugs/GLP-1s; high priced drugs; patent reforms; Pharmacy Benefit Managers; PBM related issues; and copay coupons.

Prescription drug pricing issues. S. 229 Drug-price Transparency for Consumers (DTC) Act. H.R. 3789 - The Drug-price Transparency for Consumers (DTC) Act.

Client expense: Not reported · Firm income: $90,000

No Bill No. - Reducing Medically Unnecessary Delays in Care Act No Bill No. - Global Health Empowerment and Rights (Global HER) Act No Bill No. - WHO withdrawal No Bill No. - Chronic Disease Flexible Coverage Act No Bill No. - Rural Physician Workforce Production Act No Bill No. - Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics (BLOCKING) Act No Bill No. - Protecting Patients from Deceptive Drug Ads Online Act No Bill No. - Protect Health Savings Account Act No Bill No. - HHS reorganization No Bill No. - Workforce Mobility Act No Bill No. - Health Care Workforce Expansion Act No Bill No. - TRUTH in Labeling Act No Bill No. - NIH Clinical Trial Integrity Act (H.R. 21/S.6) - Born-Alive Abortion Survivors Protection Act (H.R. 1061) - Protecting Sensitive Locations Act (S. 229) - Drug Price Transparency for Consumers (DTC) Act (H.R. 777) - Closing the College Hunger Gap Act (H.R. 957) - Parity Enforcement Act (H.R. 846/S.589) - Stop Anti-Abortion Disinformation (SAD) Act (H.R. 929/S.266) - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act (H.R. 1670/S. 797) - Family Building FEHB Fairness Act (S. 1538) - Rural Seniors Act (H.R. 999/S. 422) - Right to Contraception Act (H.R. 2818/S. 1447) - Early Childhood Nutrition Improvement Act (H.R. 2559/S. 1420) - Child Care Nutrition Enhancement Act (H.R. 2495/S. 1971) - Nutrition Counseling Aiding Recovery for Eating Disorders (CARE) Act (H.R. 2483) - SUPPORT for Patients and Communities Reauthorization Act (H.R. 2762/S. 1394) - Expanding Access to Family Planning Act (H.R. 2717/S. 1320) - Servicewoman and Veterans Menopause Research Act (H.R. 1) - One Big Beautiful Bill Act (H.R. 1026/s. 1719) - Improving Seniors' Timely Access to Care Act (H.R. 3757) - Supporting Healthy Mothers and Infants Act (S. 5469) - SHINE for Autumn Act (S. 1562/H.R. 1197) - PREEMIE Reauthorization Act (H.R. 3670) - IHS Provider Expansion Act (S. 2072) - MORE Savings Act (S. 2169) - Rural Hospital Cybersecurity Act (S. 1847/H.R. 3672) - Supporting Healthy Moms and Babies Act (H.R. 3885) - TEAMS Act (H.R. 3942) - Keeping Obstetrics Local Act (H.R. 4837) - Written Informed Consent Act (H.R. 3013) - Vaccine Transportation Act

S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now

Client expense: Not reported · Firm income: Not reported

Government targets: SENATE

H.R. 1 - One Big Beautiful Bill Act - Rep. Arrington, Jodey - Medicaid eligibility and state financing, Marketplace coverage and enrollment, Health Savings Account expansion, Pharmacy Benefit Manager financing and regulation H.R. 843 - Prompt Approval of Safe Generic Drugs Act - Rep. Barragan, Nanette Diaz - Generic drugs applications and approvals H.R. 946 - ORPHAN Cures Act - Rep. Joyce, John - Medicare Drug Negotiation Program H.R. 950 - Saving Seniors Money on Prescriptions Act - Rep. Landsman, Greg - PBM reporting requirements for MA/Part D plans H.R. 1117 - Responsibility in Drug Advertising Act - Rep. DeLauro, Rosa - Direct-to-consumer ads H.R. 1244 - Reducing Drug Prices for Seniors Act - Rep. Davis, Donald - Coinsurance for Part D drugs H.R. 2214 - DRUG Act - Rep. Miller-Meeks, Mariannette - PBM contracts H.R. 2450 - Prescription Drug Transparency and Affordability Act - Rep. McDonald Rivet, Kristen - PBM transparency H.R. 3493 - Global Fairness in Drug Pricing Act - Rep. Khanna, Ro - Prescription drug international reference pricing H.R. 3546 - Prescription Drug Price Relief Act - Rep. Khanna, Ro - Prescription drug patent reform H.R. 3775 - Fair Prescription Drug Prices for Americans Act - Rep. Van Drew, Jefferson - Prescription drug and biological product international reference pricing H.R. 3789 - DTC Act - Rep. Taylor, David - Direct-to-consumer prescription advertising transparency H.R. 4139 - Cutting Copays Act - Rep. McGarvey, Morgan - Medicare cost-sharing for generic drugs H.R. 4231 - Treat and Reduce Obesity Act - Rep. Kelly, Mike - Medicare coverage of obesity drugs H.R. 4317 - PBM Reform Act - Rep. Carter, Earl L. Buddy - PBM contracting requirements and transparency H.R. 4605 - End Prescription Drug Ads Now Act - Rep. Nadler, Jerrold - Ban on DTC drug ads H.R. 4623 - Plain Prescription Prices Act - Rep. Williams, Nikema - Transparency requirements for DTC drug ads H.R. 5094 - Protect Patients from Costly Care Act - Rep. Pappas, Chris - Repeal of Medicaid cost sharing requirements for drugs; Orphan drug inclusion in Medicare Drug Price Negotiation Program H.R. 5197 - Protect Beneficiaries from Middlemen Act - Rep. Malliotakis, Nicole - Medicare cost-sharing limit for drugs S. 229 - DTC Act - Sen. Durbin, Richard - Drug advertising requirements S. 483 - Responsibility in Drug Advertising Act - Sen. King, Angus - Drug advertising requirements S. 526 - Pharmacy Benefit Manage Transparency - Sen. Grassley, Chuck - PBM reporting requirements S. 529 - Capping Prescription Costs Act - Sen. Warnock, Raphael - Drug copay caps S. 652 - Protecting Patients from Deceptive Drugs Ads Act - Sen. Durbin, Richard - Drug advertising requirements S. 882 - Patients Before Middlemen Act - Sen. Blackburn, Marsha - PBM reforms S. 891 - Bipartisan Health Care Act - Sen. Wyden, Ron - PBM reforms and transparency S. 1040 - Drug Competition Enhanced Act - Sen. Cornyn, John - Drug patent reform S. 1041 - Affordable Prescriptions for Patients Act - Sen. Cornyn, John - Patent issues S. 1095 - Stop STALLING Act - Sen. Klobuchar, Amy - Drug patent reform S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act - Sen. Klobuchar, Amy - Drug patent reform S. 1414 - Expedited Access to Biosimilars Act - Sen. Paul, Rand - Biosimilars assessment and approval S. 1587 - Fair Prescription Drug Prices for Americans Act - Sen. Hawley, Josh - Prescription drug international reference pricing S. 1753 - End Price Gouging for Medications Act - Sen. Merkley, Jeff - Prescription drug international reference pricing S. 1818 - Prescription Drug Price Relief Act - Sen. Sanders, Bernard - Prescription drug patent reform S. 1954 - Biosimilar Red Tape Elimination Act - Sen. Lee, Mike - Biological product assessment and approval S. 1973 - Treat and Reduce Obesity Act - Sen. Cassidy, Bill - Medicare coverage for obesity drugs S. 2345 - Short on Competition Act - Sen. Klobuchar, Amy - Expedited approval for generic drugs S. 2447 - Repealing the Trump Sick Tax Act - Sen. Welch, Peter - Repeal of Medicaid cost sharing requirements for drugs; Orphan drug inclusion in Medicare Drug Price Negotiation Program S. 2620 - REMEDY Act - Sen. Durbin, Richard - Expedited approvals for certain drug approvals Issues related to the implementation of Inflation Reduction Act - Medicare negotiation; coverage of weight loss drugs; high priced drugs; patent reforms; Pharmacy Benefit Managers; PBM related issues; and copay coupons.

Issues related to prescription drug prices. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S.229 DTC Act of 2025. Issues related to H.R. 1, One Big Beautiful Bill Act.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 882; Patients Before Middlemen Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act

Client expense: $2,948,162 · Firm income: Not reported

S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years

Client expense: $2,948,162 · Firm income: Not reported

Prescription drug pricing issues. S. 229 Drug-price Transparency for Consumers (DTC) Act. H.R. 3789 - The Drug-price Transparency for Consumers (DTC) Act. H.R. 1/PL 119-21 - One Big Beautiful Bill Act.

Client expense: Not reported · Firm income: $90,000

No Bill No. - Reducing Medically Unnecessary Delays in Care Act No Bill No. - Global Health Empowerment and Rights (Global HER) Act No Bill No. - WHO withdrawal No Bill No. - Chronic Disease Flexible Coverage Act No Bill No. - Rural Physician Workforce Production Act No Bill No. - Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics (BLOCKING) Act No Bill No. - Protecting Patients from Deceptive Drug Ads Online Act No Bill No. - Protect Health Savings Account Act No Bill No. - HHS reorganization No Bill No. - Workforce Mobility Act No Bill No. - Health Care Workforce Expansion Act No Bill No. - TRUTH in Labeling Act (H.R. 21/S.6) - Born-Alive Abortion Survivors Protection Act (H.R. 1061) - Protecting Sensitive Locations Act (S. 229) - Drug Price Transparency for Consumers (DTC) Act (H.R. 777) - Closing the College Hunger Gap Act (H.R. 957) - Parity Enforcement Act (H.R. 846/S.589) - Stop Anti-Abortion Disinformation (SAD) Act (H.R. 929/S.266) - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act (H.R. 1670/S. 797) - Family Building FEHB Fairness Act (S. 1538) - Rural Seniors Act (H.R. 999/S. 422) - Right to Contraception Act (H.R. 2818/S. 1447) - Early Childhood Nutrition Improvement Act (H.R. 2559/S. 1420) - Child Care Nutrition Enhancement Act (H.R. 2495/S. 1971) - Nutrition Counseling Aiding Recovery for Eating Disorders (CARE) Act (H.R. 2483) - SUPPORT for Patients and Communities Reauthorization Act (H.R. 2762/S. 1394) - Expanding Access to Family Planning Act (H.R. 2717/S. 1320) - Servicewoman and Veterans Menopause Research Act (H.R. 1) - One Big Beautiful Bill Act (H.R. 1026/s. 1719) - Improving Seniors' Timely Access to Care Act (H.R. 3757) - Supporting Healthy Mothers and Infants Act (S. 5469) - SHINE for Autumn Act (S. 1562/H.R. 1197) - PREEMIE Reauthorization Act (H.R. 3670) - IHS Provider Expansion Act (S. 2072) - MORE Savings Act (S. 2169) - Rural Hospital Cybersecurity Act (S. 1847/H.R. 3672) - Supporting Healthy Moms and Babies Act (H.R. 3885) - TEAMS Act (H.R. 3942) - Keeping Obstetrics Local Act

H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.

Client expense: $6,630,000 · Firm income: Not reported

S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now

Client expense: Not reported · Firm income: Not reported

Government targets: SENATE

S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now

Client expense: Not reported · Firm income: Not reported

Government targets: SENATE

H.R. 1 - One Big Beautiful Bill Act - Rep. Arrington, Jodey - Medicaid eligibility and state financing, Marketplace coverage and enrollment, Health Savings Account expansion, Pharmacy Benefit Manager financing and regulation H.R. 44 - 340B Access Act - Rep. Bergman, Jack - 340B participation expansion H.R. 843 - Prompt Approval of Safe Generic Drugs Act - Rep. Barragan, Nanette Diaz - Generic drugs applications and approvals H.R. 946 - ORPHAN Cures Act - Rep. Joyce, John - Medicare Drug Negotiation Program H.R. 950 - Saving Seniors Money on Prescriptions Act - Rep. Landsman, Greg - PBM reporting requirements for MA/Part D plans. H.R. 1117 - Responsibility in Drug Advertising Act - Rep. DeLauro, Rosa - Direct-to-consumer ads H.R. 1244 - Reducing Drug Prices for Seniors Act - Rep. Davis, Donald - Coinsurance for Part D drugs H.R. 2214 - DRUG Act - Rep. Miller-Meeks, Mariannette - PBM contracts H.R. 2450 - Prescription Drug Transparency and Affordability Act - Rep. McDonald Rivet, Kristen - PBM transparency H.R. 3493 - Global Fairness in Drug Pricing Act - Rep. Khanna, Ro - Prescription drug international reference pricing H.R. 3546 - Prescription Drug Price Relief Act - Rep. Khanna, Ro - Prescription drug patent reform H.R. 3775 - Fair Prescription Drug Prices for Americans Act - Rep. Van Drew, Jefferson - Prescription drug and biological product international reference pricing H.R. 3789 - DTC Act - Rep. Taylor, David - Direct-to-consumer prescription advertising transparency S. 229 - DTC Act - Sen. Durbin, Richard - Drug advertising requirements S. 483 - Responsibility in Drug Advertising Act - Sen. King, Angus - Drug advertising requirements S. 526 - Pharmacy Benefit Manage Transparency - Sen. Grassley, Chuck - PBM reporting requirements S. 529 - Capping Prescription Costs Act - Sen. Warnock, Raphael - Drug copay caps S. 652 - Protecting Patients from Deceptive Drugs Ads Act - Sen. Durbin, Richard - Drug advertising requirements S. 882 - Patients Before Middlemen Act - Sen. Blackburn, Marsha - PBM reforms S. 891 - Bipartisan Health Care Act - Sen. Wyden, Ron - PBM reforms and transparency S. 1040 - Drug Competition Enhanced Act - Sen. Cornyn, John - Drug patent reform S. 1041 - Affordable Prescriptions for Patients Act - Sen. Cornyn, John - Patent issues S. 1095 - Stop STALLING Act - Sen. Klobuchar, Amy - Drug patent reform S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act - Sen. Klobuchar, Amy - Drug patent reform S. 1414 - Expedited Access to Biosimilars Act - Sen. Paul, Rand - Biosimilars assessment and approval S. 1587 - Fair Prescription Drug Prices for Americans Act - Sen. Hawley, Josh - Prescription drug international reference pricing S. 1753 - End Price Gouging for Medications Act - Sen. Merkley, Jeff - Prescription drug international reference pricing S. 1818 - Prescription Drug Price Relief Act - Sen. Sanders, Bernard - Prescription drug patent reform S. 1954 - Biosimilar Red Tape Elimination Act - Sen. Lee, Mike - Biological product assessment and approval Issues related to the implementation of Inflation Reduction Act - Medicare negotiation; coverage of weight loss drugs; high priced drugs; patent reforms; Pharmacy Benefit Managers; PBM related issues; and copay coupons.

Issues related to prescription drug prices. S.1041 Affordable Prescriptions for Patients Act. Fair Accountability and Innovative Research Drug Pricing Act. S.229 Drug Price Transparency for Consumers Act.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3178 / S. 1600, The Save Healthcare Workers Act, all provisions; H.R. 3266 / S. 1673, Mental Health Infrastructure Improvement Act, all provisions; H.R. 929 / S. 266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions; H.R. 1585 / S. 709, Conrad State 30 and Physician Access Reauthorization Act, all provisions; Draft Bill, Healthcare Workforce Resilience Act, all provisions; Draft Bill, 340B PATIENTS Act, all provisions; H.R. 593, The Strengthening Pathways to Health Professions Act, all provisions; S.Res.230, A resolution supporting the goals and ideals of National Hospital Week, to be observed from May 11 through May 17, 2025, all provisions; Draft Bill , The Pharmaceutical Supply Chain Risk Assessment Act of 2023, all provisions; S. 1784 / H.R. 4191, The Mapping America's Pharmaceutical Supply (MAPS) Act, all provisions; S. 229 / H.R. 3789, Drug Price Transparency for Consumer (DTC) Act, all provisions; S. 2062, Rapid Reserve Act, all provisions; Draft Bill, Medical Debt Prevention and Relief Act of 2025, all provisions; S. 1929, SEPSIS Act, all provisions; H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025, all provisions; S. 547, Train More Nurses Act, all provisions; Draft Bill, Issues pertaining to organ donations; Federal Emergency Management Agency (FEMA), RFI; The FEMA public assistance program; U.S. Department of Justice & Federal Trade Commission, Anticompetitive Deregulations, Recommendations for addressing regulations that foster anticompetitive conduct by insurers and limit the ability of hospitals and health systems to thrive in a competitive free market, among others; U.S. Department of Health and Human Services, Request for Information: Deregulation, Comments on how to eliminate burdensome and wasteful administrative requirements for hospitals and health systems; Enhanced Premium Tax Credits, Extension of Enhanced Premium Tax Credits; Rural Health Care Access, Issues to protect access to rural health care; 340B Program, Issues pertaining to protecting 340B Program; Maternal and Child Health, Access to maternal and child health care and addressing related workforce shortages, conditions of participation (COP), funding priorities; Behavioral Health, Issues related to expanding access to care and reducing regulatory barriers; Workforce, Nurse staffing mandate, workforce development programs; Health Care Resiliency & Preparedness, Issues pertaining to natural disasters, cyberattacks, and securing supply chains; Post-Acute Care, Issues pertaining to expanding patients' access to crucial services provided by Long-term care hospitals, inpatient rehabilitation facilities, skilled nursing facilities, and home health agencies; Health Plan Accountability, Issues specific to prior authorization, patient access to care, adequate provider networks, inappropriate denials, reducing account receivables, prompt pay; Rural Emergency Hospital designation, Issues pertaining to eligibility and payment rates for the Rural Emergency Hospital designation; Tax-exempt status, Issues pertaining to not-for-profit hospitals' tax exempt status and tax-exempt private activity bonds; Health Care Access, Issues pertaining to protecting patients access to the health insurance marketplaces; Price Transparency, Issues related to hospital price transparency.

S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act S. 229; Drug-price Transparency for Consumers Act H.R. 3789; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act S. 1302; Increasing Transparency in Generic Drug Application Act H.R. 2484; Seniors Access to Critical Medications Act

Client expense: $3,428,860 · Firm income: Not reported

Prescription drug pricing issues. S. 229 Drug-price Transparency for Consumers (DTC) Act. H.R. 3789 - The Drug-price Transparency for Consumers (DTC) Act. H.R. 1 - One Big Beautiful Bill Act.

Client expense: Not reported · Firm income: $90,000

H.R. 1, One Big Beautiful Bill Act. S. 1862/ H.R. 946, the Optimizing Research Progress Hope And New Cures (ORPHAN Cures) Act. S. 832, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. No bill number. Discussed the Medicare drug price negotiation program. Discussed pharmacy benefit manager reforms. S. 229/ H.R. 3789, the Drug-Price Transparency for Consumers (DTC) Act of 2025. S. 1096, Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. S. 1040, Drug Competition Enhancement Act. S. 1041, Affordable Prescriptions for Patients Act.

Client expense: $5,120,000 · Firm income: Not reported

No Bill No. - Reducing Medically Unnecessary Delays in Care Act No Bill No. - Global Health Empowerment and Rights (Global HER) Act No Bill No. - WHO withdrawal No Bill No. - Chronic Disease Flexible Coverage Act No Bill No. - Rural Physician Workforce Production Act No Bill No. - Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics (BLOCKING) Act No Bill No. - Protecting Patients from Deceptive Drug Ads Online Act No Bill No. - Protect Health Savings Account Act No Bill No. - HHS reorganization No Bill No. - Keeping Obstetrics Local Act No Bill No. - Workforce Mobility Act (H.R. 21/S.6) - Born-Alive Abortion Survivors Protection Act (H.R. 1061) - Protecting Sensitive Locations Act (S. 229) - Drug Price Transparency for Consumers (DTC) Act (H.R. 777) - Closing the College Hunger Gap Act (H.R. 957) - Parity Enforcement Act (H.R. 846/S.589) - Stop Anti-Abortion Disinformation (SAD) Act (H.R. 929/S.266) - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act (H.R. 1670/S. 797) - Family Building FEHB Fairness Act (S. 1538) - Rural Seniors Act (H.R. 999/S. 422) - Right to Contraception Act (H.R. 2818/S. 1447) - Early Childhood Nutrition Improvement Act (H.R. 2559/S. 1420) - Child Care Nutrition Enhancement Act (H.R. 2495/S. 1971) - Nutrition Counseling Aiding Recovery for Eating Disorders (CARE) Act (H.R. 2483) - SUPPORT for Patients and Communities Reauthorization Act (H.R. 2762/S. 1394) - Expanding Access to Family Planning Act (H.R. 2717/S. 1320) - Servicewoman and Veterans Menopause Research Act (H.R. 1) - One Big Beautiful Bill Act (H.R. 1026/s. 1719) - Improving Seniors' Timely Access to Care Act (H.R. 3757) - Supporting Healthy Mothers and Infants Act

Client expense: $1,203,565 · Firm income: Not reported

H.R. 44 - 340B Access Act - Rep. Bergman, Jack - 340B participation expansion H.R. 843 - Prompt Approval of Safe Generic Drugs Act - Rep. Barragan, Nanette Diaz - Generic drugs applications and approvals H.R. 946 - ORPHAN Cures Act - Rep. Joyce, John - Medicare Drug Negotiation Program H.R. 950 - Saving Seniors Money on Prescriptions Act - Rep. Landsman, Greg - PBM reporting requirements for MA/Part D plans. H.R. 1117 - Responsibility in Drug Advertising Act - Rep. DeLauro, Rosa - Direct-to-consumer ads H.R. 1244 - Reducing Drug Prices for Seniors Act - Rep. Davis, Donald - Coinsurance for Part D drugs H.R. 2214 - DRUG Act - Rep. Miller-Meeks, Mariannette - PBM contracts H.R. 2450 - Prescription Drug Transparency and Affordability Act - Rep. McDonald Rivet, Kristen - PBM transparency S. 229 - DTC Act - Sen. Durbin, Richard - Drug advertising requirements S. 483 - Responsibility in Drug Advertising Act - Sen. King, Angus - Drug advertising requirements S. 526 - Pharmacy Benefit Manage Transparency - Sen. Grassley, Chuck - PBM reporting requirements S. 529 - Capping Prescription Costs Act - Sen. Warnock, Raphael - Drug copay caps S. 652 - Protecting Patients from Deceptive Drugs Ads Act - Sen. Durbin, Richard - Drug advertising requirements S. 882 - Patients Before Middlemen Act - Sen. Blackburn, Marsha - PBM reforms S. 891 - Bipartisan Health Care Act - Sen. Wyden, Ron - PBM reforms and transparency S. 1040 - Drug Competition Enhanced Act - Sen. Cornyn, John - Drug patent reform S. 1041 - Affordable Prescriptions for Patients Act - Sen. Cornyn, John - Patent issues S. 1095 - Stop STALLING Act - Sen. Klobuchar, Amy - Drug patent reform S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act - Sen. Klobuchar, Amy - Drug patent reform Issues related to the implementation of Inflation Reduction Act - Medicare negotiation; coverage of weight loss drugs; high priced drugs; patent reforms; Pharmacy Benefit Managers; and copay coupons.

DRAFTBill, the Safety from Violence for Healthcare Employees (SAVE) Act, all provisions; H.R.929 / S. 266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions; DRAFT Bill, Mental Health Infrastructure Improvement Act, all provisions; H.R. 1585 / S. 709, Conrad State 30 and Physician Access Reauthorization Act, all provisions; DRAFT Bill, Healthcare Workforce Resilience Act, all provisions; DRAFT Bill, 340B PATIENTS Act , all provisions; H.R. 1417, The Rural Health Care Technical Assistance Program Act, all provisions; S. 229, Drug-price Transparency for Consumers (DTC) Act, all provisions; H.R.330, Organ Donation Referral Improvement Act, Issues pertaining to organ donation referral process; S. 526, Pharmacy Benefit Manager Reform Act, Pharmacy benefit management services; Drug Enforcement Administration, DEAs proposed rule; Physician-Focused Payment Model Technical Advisory Committee, Population-based total cost-of-care; Tax-exempt status, Issues pertaining to not-for-profit hospitals' tax exempt status and tax-exempt private activity bonds; Enhanced Premium Tax Credits, Extension of Enhanced Premium Tax Credits; Price Transparency, Issues related to hospital price transparency; Rural Health Care Access, Issues to protect access to rural health care; 340B Program, Issues pertaining to protecting 340B Program; Maternal and Child Health, Access to maternal and child health care and addressing related workforce shortages, conditions of participation (COP); Behavioral Health, Issues related to expanding access to care and reducing regulatory barriers; Workforce, Nurse staffing mandate, workforce development programs; Health Care Resiliency & Preparedness, Issues pertaining to natural disasters, cyberattacks, and securing supply chains; Post-Acute Care, Issues pertaining to how Congress can better support patients' access to crucial services provided by Long-term care hospitals, inpatient rehabilitation facilities, skilled nursing facilities, and home health agencies; Health Plan Accountability, Issues specific to prior authorization, patient access to care, adequate provider networks, inappropriate denials, reducing account receivables, prompt pay; Hospital mergers and acquisitions, Issues pertaining to hospital consolidation, mergers an acquisition, physician practice acquisition, FTC premerger notification rules; Rural Emergency Hospital Designation, Issues pertaining to eligibility for the Rural Emergency Hospital designation and the expansion of physician-owned hospitals.

Issues related to prescription drug prices. S.1041 Affordable Prescriptions for Patients Act. Fair Accountability and Innovative Research Drug Pricing Act. S.229 Drug Price Transparency for Consumers Act.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.

Client expense: $6,630,000 · Firm income: Not reported

Prescription drug pricing issues. S. 229 Drug-price Transparency for Consumers (DTC) Act.

Client expense: Not reported · Firm income: $90,000

No Bill No. - Reducing Medically Unnecessary Delays in Care Act No Bill No. - Global Health Empowerment and Rights (Global HER) Act No Bill No. - WHO withdrawal No Bill No. - Chronic Disease Flexible Coverage Act No Bill No. - Rural Physician Workforce Production Act No Bill No. - Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics (BLOCKING) Act No Bill No. - Protecting Patients from Deceptive Drug Ads Online Act (H.R. 21/S.6) - Born-Alive Abortion Survivors Protection Act (H.R. 1061) - Protecting Sensitive Locations Act (S. 229) - Drug Price Transparency for Consumers (DTC) Act (H.R. 777) - Closing the College Hunger Gap Act (H.R. 957) - Parity Enforcement Act (H.R. 846/S.589) - Stop Anti-Abortion Disinformation (SAD) Act (H.R. 929/S.266) - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act (H.R. 1670/S. 797) - Family Building FEHB Fairness Act

Client expense: $1,133,128 · Firm income: Not reported